GSK vs. HSBA.L
GSK (GlaxoSmithKline plc) and HSBA.L (HSBC Holdings plc) are both stocks. GSK operates in Drug Manufacturers - General (Healthcare), while HSBA.L operates in Banks - Diversified (Financial Services). Over the past 10 years, GSK returned 4.64%/yr vs 17.27%/yr for HSBA.L. At a 0.33 correlation, their price movements are largely independent.
Performance
GSK vs. HSBA.L - Performance Comparison
Loading charts...
Different Trading Currencies
GSK is traded in USD, while HSBA.L is traded in GBp. To make them comparable, the HSBA.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, GSK achieves a 4.91% return, which is significantly lower than HSBA.L's 19.57% return. Over the past 10 years, GSK has underperformed HSBA.L with an annualized return of 4.64%, while HSBA.L has yielded a comparatively higher 17.27% annualized return.
GSK
- 1D
- -1.71%
- 1M
- 1.25%
- YTD
- 4.91%
- 6M
- 6.15%
- 1Y
- 27.36%
- 3Y*
- 17.87%
- 5Y*
- 4.68%
- 10Y*
- 4.64%
HSBA.L
- 1D
- 0.82%
- 1M
- 2.25%
- YTD
- 19.57%
- 6M
- 33.16%
- 1Y
- 60.71%
- 3Y*
- 43.51%
- 5Y*
- 32.16%
- 10Y*
- 17.27%
GSK vs. HSBA.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GSK GlaxoSmithKline plc | 4.91% | 51.23% | -5.14% | 9.71% | -33.41% | 26.74% | -17.72% | 29.24% | 13.79% | -2.97% |
HSBA.L HSBC Holdings plc | 19.57% | 69.67% | 34.16% | 39.11% | 7.09% | 21.78% | -34.03% | 1.50% | -16.08% | 35.30% |
Correlation
The correlation between GSK and HSBA.L is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jul 5, 2007 | 0.33 |
The correlation between GSK and HSBA.L shifts across timeframes, from 0.22 (3 years) to 0.33 (all time), reflecting how their relationship changes across market environments.
Fundamentals
GSK:
$103.15B
HSBA.L:
£237.12B
GSK:
$2.85
HSBA.L:
£1.27
GSK:
17.78
HSBA.L:
10.80
GSK:
1.19
HSBA.L:
0.52
GSK:
3.16
HSBA.L:
1.91
GSK:
4.38
HSBA.L:
1.36
GSK:
$32.78B
HSBA.L:
£125.68B
GSK:
$23.87B
HSBA.L:
£61.95B
GSK:
$11.30B
HSBA.L:
£31.98B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GSK vs. HSBA.L — Risk / Return Rank
GSK
HSBA.L
GSK vs. HSBA.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GlaxoSmithKline plc (GSK) and HSBC Holdings plc (HSBA.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GSK | HSBA.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.18 | ||
| Sortino ratioReturn per unit of downside risk | -1.24 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.40 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | 1.48 | 3.54 | -2.06 |
| Martin ratioReturn relative to average drawdown | 3.38 | 12.89 | -9.50 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GSK | HSBA.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.02 | 2.20 | -1.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.19 | 1.21 | -1.02 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.20 | 0.65 | -0.45 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.14 | +0.18 |
Drawdowns
GSK vs. HSBA.L - Drawdown Comparison
The maximum GSK drawdown since its inception was -55.70%, smaller than the maximum HSBA.L drawdown of -75.69%. Use the drawdown chart below to compare losses from any high point for GSK and HSBA.L.
Loading charts...
Drawdown Indicators
| GSK | HSBA.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.70% | -75.69% | +19.99% |
Max Drawdown (1Y)Largest decline over 1 year | -18.63% | -17.07% | -1.56% |
Max Drawdown (3Y)Largest decline over 3 years | -28.46% | -21.55% | -6.91% |
Max Drawdown (5Y)Largest decline over 5 years | -50.10% | -32.36% | -17.74% |
Max Drawdown (10Y)Largest decline over 10 years | -50.10% | -63.05% | +12.95% |
Current DrawdownCurrent decline from peak | -15.91% | -3.66% | -12.25% |
Average DrawdownAverage peak-to-trough decline | -18.87% | -34.38% | +15.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.11% | 4.68% | +3.43% |
Volatility
GSK vs. HSBA.L - Volatility Comparison
GlaxoSmithKline plc (GSK) and HSBC Holdings plc (HSBA.L) have volatilities of 6.42% and 6.69%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GSK | HSBA.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.42% | 6.69% | -0.27% |
Volatility (6M)Calculated over the trailing 6-month period | 18.51% | 22.87% | -4.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.94% | 27.52% | -0.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.06% | 26.66% | -1.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.89% | 26.39% | -3.50% |
Dividends
GSK vs. HSBA.L - Dividend Comparison
GSK's dividend yield for the trailing twelve months is around 3.41%, less than HSBA.L's 4.06% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK GlaxoSmithKline plc | 3.41% | 3.42% | 4.60% | 3.75% | 5.47% | 4.99% | 5.59% | 4.35% | 5.65% | 5.83% | 6.86% | 5.93% |
HSBA.L HSBC Holdings plc | 4.06% | 4.28% | 8.28% | 6.80% | 4.11% | 3.54% | 0.00% | 6.79% | 5.83% | 5.18% | 0.00% | 0.00% |
Financials
GSK vs. HSBA.L - Financials Comparison
This section allows you to compare key financial metrics between GlaxoSmithKline plc and HSBC Holdings plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GSK vs. HSBA.L - Profitability Comparison
GSK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported a gross profit of 5.75B and revenue of 7.63B. Therefore, the gross margin over that period was 75.4%.
HSBA.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, HSBC Holdings plc reported a gross profit of 15.89B and revenue of 31.56B. Therefore, the gross margin over that period was 50.4%.
GSK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported an operating income of 2.29B and revenue of 7.63B, resulting in an operating margin of 30.1%.
HSBA.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, HSBC Holdings plc reported an operating income of 9.18B and revenue of 31.56B, resulting in an operating margin of 29.1%.
GSK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, GlaxoSmithKline plc reported a net income of 1.74B and revenue of 7.63B, resulting in a net margin of 22.8%.
HSBA.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, HSBC Holdings plc reported a net income of 7.19B and revenue of 31.56B, resulting in a net margin of 22.8%.
Frequently Asked Questions
GSK and HSBA.L have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for GSK and HSBA.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer